ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in ESSA Pharma Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −3 vs. Q2 2023
- Shares held
- 33.5M
- +219.7K (+0.7%) vs. Q2 2023
- Total value
- $103.4M
- +$13.6M (+15.2%) vs. Q2 2023
- New holders
- 1
- 10 more added
- Sold out
- 4
- 10 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 8,748,629 | $27.0M | 0.73% | 00.0% | Unchanged |
| Bellevue Group AG | 7,898,583 | $24.4M | 0.39% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 4,287,094 | $13.2M | 1.33% | +85,000+2.0% | Added |
| PFM Health Sciences, LP | 4,199,253 | $13.0M | 0.62% | −5,700−0.1% | Reduced |
| Morgan Stanley | 4,182,683 | $12.9M | 0.00% | +312,603+8.1% | Added |
| Adage Capital Partners GP, L.L.C. | 1,042,531 | $3.22M | 0.01% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 842,366 | $2.60M | 0.06% | −79,574−8.6% | Reduced |
| Rock Springs Capital Management LP | 677,005 | $2.09M | 0.06% | +13,688+2.1% | Added |
| Millennium Management LLC | 473,556 | $1.46M | 0.00% | +4,554+1.0% | Added |
| Rhenman & Partners Asset Management AB | 356,500 | $1.10M | 0.12% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 168,050 | $519.3K | 0.00% | 00.0% | Unchanged |
| CIBC World Markets Inc. | 149,143 | $461.0K | 0.00% | −11,500−7.2% | Reduced |
| Susquehanna International Group, LLP | 95,758 | $295.9K | 0.00% | +46,228+93.3% | Added |
| Connective Capital Management, LLC | 84,578 | $261.3K | 0.60% | −58,149−40.7% | Reduced |
| Two Sigma Advisers, LP | 56,900 | $175.8K | 0.00% | −25,400−30.9% | Reduced |
| Group One Trading, L.P. | 41,860 | $129.3K | 0.01% | +10,596+33.9% | Added |
| JPMorgan Chase & Co | 29,427 | $90.9K | 0.00% | −14,446−32.9% | Reduced |
| BNP Paribas Arbitrage, SA | 21,695 | $67.0K | 0.00% | +7,290+50.6% | Added |
| Privium Fund Management (UK) Ltd | 20,032 | $61.1K | 0.05% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 19,039 | $58.8K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 15,903 | $48.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 15,188 | $46.9K | 0.00% | −6,758−30.8% | Reduced |
| Advisor Group Holdings, Inc. | 12,000 | $37.1K | 0.00% | +6,775+129.7% | Added |
| Hunting Hill Global Capital, LLC | 10,000 | $30.9K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 7,677 | $23.7K | 0.00% | +5,416+239.5% | Added |
| Citadel Advisors LLC | 5,475 | $16.9K | 0.00% | −5,408−49.7% | Reduced |
| Simplex Trading, LLC | 3,669 | $11.0K | 0.00% | −2,020−35.5% | Reduced |
| Royal Bank of Canada | 1,498 | $4.00K | 0.00% | +723+93.3% | Added |
| Barclays PLC | 1,288 | $3.98K | 0.00% | +1,288 | New |
| TD Waterhouse Canada Inc. | 900 | $2.64K | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Advisors LLC | 600 | $1.85K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 165 | $510 | 0.00% | −265−61.6% | Reduced |
| Federation des caisses Desjardins du Quebec | 50 | $155 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 48 | $148 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 31 | $96 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8 | $25 | 0.00% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −28,300−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −24,414−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −12,489−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −27−100.0% | Sold out |